BSE Live
Mar 28, 16:01Prev. Close
206.40
Open Price
207.00
Bid Price (Qty.)
202.35 (441)
Offer Price (Qty.)
202.35 (38)
NSE Live
Mar 28, 15:59Prev. Close
206.65
Open Price
206.65
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
202.50 (1103)
Nine Months Results of Biocon (in Rs. Cr.) | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | |
Net Sales/Income from operations | 1,486.20 | 1,220.50 | 1,536.80 | 1,506.00 | 2,120.80 | |
Other Operating Income | -- | -- | -- | -- | -- | |
Total Income From Operations | 1,486.20 | 1,220.50 | 1,536.80 | 1,506.00 | 2,120.80 | |
EXPENDITURE | ||||||
Consumption of Raw Materials | 716.10 | 654.40 | 582.20 | 610.90 | 914.80 | |
Purchase of Traded Goods | 2.10 | 1.70 | 0.70 | 70.10 | 105.90 | |
Increase/Decrease in Stocks | -20.20 | -102.60 | 27.60 | -66.90 | -88.20 | |
Power & Fuel | -- | -- | -- | -- | -- | |
Employees Cost | 326.20 | 273.90 | 293.20 | 254.90 | 370.80 | |
Depreciation | 87.50 | 80.10 | 78.10 | 73.40 | 109.60 | |
Excise Duty | -- | -- | -- | -- | -- | |
Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
R & D Expenses | -- | -- | -- | -- | -- | |
Provisions And Contingencies | -- | -- | -- | -- | -- | |
Exp. Capitalised | -- | -- | -- | -- | -- | |
Other Expenses | 394.50 | 358.50 | 390.30 | 394.40 | 530.30 | |
P/L Before Other Inc. , Int., Excpt. Items & Tax | -20.00 | -45.50 | 164.70 | 169.20 | 177.60 | |
Other Income | 207.40 | 126.40 | 108.10 | 134.50 | 103.50 | |
P/L Before Int., Excpt. Items & Tax | 187.40 | 80.90 | 272.80 | 303.70 | 281.10 | |
Interest | 21.50 | 0.40 | 0.30 | 1.00 | 2.00 | |
P/L Before Exceptional Items & Tax | 165.90 | 80.50 | 272.50 | 302.70 | 279.10 | |
Exceptional Items | 1,009.20 | -- | -- | 137.00 | 198.70 | |
P/L Before Tax | 1,175.10 | 80.50 | 272.50 | 439.70 | 477.80 | |
Tax | 137.50 | 32.50 | 59.70 | 97.00 | 55.60 | |
P/L After Tax from Ordinary Activities | 1,037.60 | 48.00 | 212.80 | 342.70 | 422.20 | |
Prior Year Adjustments | -- | -- | -- | -- | -- | |
Extra Ordinary Items | -- | -- | -- | -4.00 | -- | |
Net Profit/(Loss) For the Period | 1,037.60 | 48.00 | 212.80 | 338.70 | 422.20 | |
Equity Share Capital | 600.30 | 600.30 | 600.00 | 600.00 | 300.00 | |
Reserves Excluding Revaluation Reserves | -- | -- | -- | -- | -- | |
Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
EPS Before Extra Ordinary | ||||||
Basic EPS | 8.70 | 0.40 | 1.79 | 2.86 | 7.14 | |
Diluted EPS | 8.68 | 0.40 | 1.78 | 2.85 | 7.09 | |
EPS After Extra Ordinary | ||||||
Basic EPS. | 8.70 | 0.40 | 1.79 | 2.86 | 7.14 | |
Diluted EPS. | 8.68 | 0.40 | 1.78 | 2.85 | 7.09 | |
Public Share Holding | ||||||
No Of Shares (Crores) | -- | -- | -- | -- | -- | |
Share Holding (%) | -- | -- | -- | -- | -- | |
Promoters and Promoter Group Shareholding | ||||||
a) Pledged/Encumbered | ||||||
- Number of shares (Crores) | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
b) Non-encumbered | ||||||
- Number of shares (Crores) | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- |
20.02.2023
Biocon Standalone December 2022 Net Sales at Rs 555.00 crore, up 17.34% Y-o-Y
17.02.2023
Biocon Consolidated December 2022 Net Sales at Rs 2,941.10 crore, up 35.27% Y-o-Y
15.11.2022
Biocon Standalone September 2022 Net Sales at Rs 489.50 crore, up 34.18% Y-o-Y
15.11.2022
Biocon Consolidated September 2022 Net Sales at Rs 2,319.70 crore, up 26.04% Y-o-Y